14-93721504-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_178013.4(PRIMA1):c.402G>A(p.Glu134=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000198 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
PRIMA1
NM_178013.4 synonymous
NM_178013.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.880
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 14-93721504-C-T is Benign according to our data. Variant chr14-93721504-C-T is described in ClinVar as [Benign]. Clinvar id is 476373.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.88 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRIMA1 | NM_178013.4 | c.402G>A | p.Glu134= | synonymous_variant | 5/5 | ENST00000393140.6 | NP_821092.1 | |
PRIMA1 | XM_011536456.3 | c.402G>A | p.Glu134= | synonymous_variant | 5/5 | XP_011534758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRIMA1 | ENST00000393140.6 | c.402G>A | p.Glu134= | synonymous_variant | 5/5 | 1 | NM_178013.4 | ENSP00000376848 | P1 | |
PRIMA1 | ENST00000393143.5 | c.402G>A | p.Glu134= | synonymous_variant | 4/4 | 1 | ENSP00000376851 | P1 | ||
PRIMA1 | ENST00000316227.3 | c.*198G>A | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000320948 | ||||
PRIMA1 | ENST00000477603.5 | c.*198G>A | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 1 | ENSP00000434370 |
Frequencies
GnomAD3 genomes AF: 0.00108 AC: 164AN: 152132Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
164
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251286Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135822
GnomAD3 exomes
AF:
AC:
63
AN:
251286
Hom.:
AF XY:
AC XY:
24
AN XY:
135822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000106 AC: 155AN: 1461698Hom.: 0 Cov.: 32 AF XY: 0.0000976 AC XY: 71AN XY: 727158
GnomAD4 exome
AF:
AC:
155
AN:
1461698
Hom.:
Cov.:
32
AF XY:
AC XY:
71
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00108 AC: 165AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.00102 AC XY: 76AN XY: 74420
GnomAD4 genome
AF:
AC:
165
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
76
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Sleep-related hypermotor epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
PRIMA1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 12, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at